Main menu button

News

Equity Research Zazz Energy, Q2 2023: Intense quarter and restart expected soon
25 Aug 2023
Equity Research Zazz Energy, Q2 2023: Intense quarter and restart expected soon
Equity Research
Equity research Observit, Q2 2023: Strong performance from software company
24 Aug 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research Observit
Equity Research Zazz Energy, Q2 2023: Intensive quarter awaiting the restart of the Amfilochia plant
23 Aug 2023
Equity Research Zazz Energy, Q2 2023: Intensive quarter awaiting the restart of the Amfilochia plant
Equity Research
Equity Research, Pharmiva: Merger with Peptonic could spark the fire
23 Aug 2023
Equity Research, Pharmiva: Merger with Peptonic could spark the fire
Equity Research
Carlsquare weekly market letter: China and the US are dithering. The boat is rocking
23 Aug 2023
Carlsquare weekly market letter: China and the US are dithering. The boat is rocking
Equity Research Carlsquare
Equity research Observit, Q2 2023: Strong performance from software company
22 Aug 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research Observit
Equity research update Kancera: Heart infarction results expected soon
22 Aug 2023
Equity research update Kancera: Heart infarction results expected soon
Equity Research Kancera
Research Update InCoax, Q2 2023: A potential new Tier 1 operating customer
21 Aug 2023
Research Update InCoax, Q2 2023: A potential new Tier 1 operating customer
Equity Research InCoax
Research Update Ecoclime, Q2 2023: Sales growth much better than expected
18 Aug 2023
Research Update Ecoclime, Q2 2023: Sales growth much better than expected
Equity Research
First Impression InCoax, Q2 2023: Sales lower than expected, but good gross margin
18 Aug 2023
First Impression InCoax, Q2 2023: Sales lower than expected, but good gross margin
Equity Research InCoax
Equity research Risk Intelligence, Q2 2023: A strong quarter throughout
18 Aug 2023
Equity research Risk Intelligence, Q2 2023: A strong quarter throughout
Equity Research Risk Intelligence
First Impression Ecoclime, Q2 2023: 34% higher revenues than expected
17 Aug 2023
First Impression Ecoclime, Q2 2023: 34% higher revenues than expected
Equity Research
Research Update Biosergen, Q2 2023: Stable in costs but delays in clinical timeline
16 Aug 2023
Research Update Biosergen, Q2 2023: Stable in costs but delays in clinical timeline
Equity Research Biosergen
Equity Research Risk Intelligence, Q2 2023: Better than expected revenues and profitability
16 Aug 2023
Equity Research Risk Intelligence, Q2 2023: Better than expected revenues and profitability
Equity Research Risk Intelligence
Carlsquare weekly market letter: The market breaks downwards
16 Aug 2023
Carlsquare weekly market letter: The market breaks downwards
Equity Research Carlsquare
Research Update H&D Wireless, Q2 2023: Good order intake, but not yet break-even
14 Aug 2023
Research Update H&D Wireless, Q2 2023: Good order intake, but not yet break-even
Equity Research
Video Interview H&D Wireless
11 Aug 2023
Video Interview H&D Wireless
Equity Research
First Impression H&D Wireless, Q2 2023: Improved order intake
11 Aug 2023
First Impression H&D Wireless, Q2 2023: Improved order intake
Equity Research
Carlsquare weekly market letter: Oil and inflation stir emotions
09 Aug 2023
Carlsquare weekly market letter: Oil and inflation stir emotions
Equity Research Carlsquare
Equity research update HANZA Q2 2023: Higher profitability confirmed
27 Jul 2023
Equity research update HANZA Q2 2023: Higher profitability confirmed
Equity Research Hanza